Thorp Clay
Insider CIK 1592380 · PHAS Director, 10% owner · CLSD Director, 10% owner · GTHX 10% owner · VIGL Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CLSD Clearside Biomedical, Inc. | P Buy | 2025-02-24 | 2025-02-24 | 15,000 | $0.92 | $13.8K | 176,141 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 45,000 | — | $0 | 45,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2023-09-25 | 2023-09-25 | 10,000 | $0.86 | $8.6K | 40,522 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise | 2023-05-19 | 2023-05-19 | 3,750 | — | $0 | 36,693 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2022-12-21 | 2022-12-21 | 14,000 | $1.02 | $14.3K | 30,522 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | J Other | 2022-12-15 | 2022-12-19 | 8,522 | — | $0 | 16,522 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | J Other | 2022-12-15 | 2022-12-19 | 1,406,507 | — | $0 | 3,545,040 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 30,000 | — | $0 | 30,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2022-05-19 | 2022-05-20 | 3,750 | — | $0 | 3,750 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | P Buy | 2022-05-17 | 2022-05-17 | 14,893 | $2.97 | $44.2K | 1,556,030 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | P Buy | 2022-05-16 | 2022-05-17 | 21,802 | $2.76 | $60.2K | 1,541,137 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | P Buy | 2022-03-28 | 2022-03-28 | 3,000 | $7.20 | $21.6K | 3,000 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 2,552,021 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 926,506 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | P Buy | 2022-01-11 | 2022-01-11 | 265,000 | $14.00 | $3.71M | 1,519,335 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion | 2022-01-11 | 2022-01-11 | 1,254,335 | — | $0 | 1,254,335 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2021-08-18 | 2021-08-18 | 10,000 | $3.00 | $30.0K | 32,943 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2021-06-10 | 2021-06-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2021-06-03 | 2021-06-04 | 14,000 | — | $0 | 14,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2021-02-10 | 2022-12-19 | 32,873 | $4.43 | $145.6K | 4,951,547 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2021-02-10 | 2021-02-12 | 32,873 | $4.43 | $145.6K | 3,433,521 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2020-11-24 | 2020-11-24 | 2,000 | $3.50 | $7.0K | 22,943 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2020-11-23 | 2020-11-24 | 3,000 | $3.67 | $11.0K | 20,943 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | J Other | 2020-11-16 | 2020-11-18 | 10,586 | — | $0 | 15,432 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | J Other | 2020-11-16 | 2020-11-18 | 2,144 | — | $0 | 17,943 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | J Other | 2020-11-16 | 2020-11-18 | 52,397 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2020-06-03 | 2020-06-05 | 16,000 | — | $0 | 16,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award | 2019-11-22 | 2019-11-26 | 1,518,026 | $1.05 | $1.59M | 4,984,420 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale | 2019-07-01 | 2019-07-03 | 180 | $14.00 | $2.5K | 162,890 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale | 2019-07-01 | 2019-07-03 | 255 | $14.00 | $3.6K | 52,397 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale | 2019-07-01 | 2019-07-03 | 459 | $14.00 | $6.4K | 415,959 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale | 2019-07-01 | 2019-07-03 | 2,014 | $14.00 | $28.2K | 1,818,638 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2019-06-20 | 2019-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale | 2019-06-18 | 2019-06-20 | 63 | $14.00 | $882 | 416,418 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale | 2019-06-18 | 2019-06-20 | 277 | $14.00 | $3.9K | 1,820,656 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale | 2019-06-18 | 2019-06-20 | 35 | $14.00 | $490 | 52,655 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale | 2019-06-18 | 2019-06-20 | 25 | $14.00 | $350 | 163,074 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-05-09 | 2019-05-13 | 11,000 | — | $0 | 11,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | A Award deriv | 2019-02-27 | 2019-03-01 | 36,000 | — | $0 | 36,000 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2018-12-06 | 2018-12-06 | 8,000 | $1.36 | $10.9K | 8,000 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-12-04 | 2018-12-06 | 4,000 | $3.13 | $12.5K | 15,799 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 42 | $5.00 | $210 | 94,874 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 1,731 | $0.12 | $208 | 94,916 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 1,731 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 458 | $5.00 | $2.3K | 1,044,764 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 19,061 | $0.12 | $2.3K | 1,045,222 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 19,061 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 226,061 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 24,709 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 272,107 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 40,420 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 13,558 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 149,320 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 94,874 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 1,044,764 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 13,609 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 174,699 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 4,846 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 3,862 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 42,530 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion deriv | 2018-10-22 | 2018-10-24 | 52,690 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 994 | $5.00 | $5.0K | 40,420 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 41,414 | $0.12 | $5.0K | 41,414 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 41,414 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 104 | $5.00 | $520 | 13,558 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 4,309 | $0.12 | $517 | 13,662 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 4,309 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | S Sale deriv | 2018-10-22 | 2018-10-24 | 1,139 | $5.00 | $5.7K | 149,320 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 47,458 | $0.12 | $5.7K | 150,459 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | M Exercise deriv | 2018-10-22 | 2018-10-24 | 47,458 | — | $0 | 0 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 1,683,420 | — | $0 | 1,683,420 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 52,690 | — | $0 | 52,690 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 4,846 | — | $0 | 4,846 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 266,481 | — | $0 | 266,481 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 137,513 | $5.00 | $687.6K | 1,820,933 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | C Conversion | 2018-10-22 | 2018-10-24 | 150,612 | — | $0 | 150,612 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 12,487 | $5.00 | $62.4K | 163,099 | SEC↗ |
| PHAS PhaseBio Pharmaceuticals I | P Buy | 2018-10-22 | 2018-10-24 | 150,000 | $5.00 | $750.0K | 416,481 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2018-06-20 | 2018-06-21 | 11,250 | — | $0 | 11,250 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-30 | 2018-06-01 | 41,710 | $48.00 | $2.00M | 3,237,711 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-30 | 2018-06-01 | 758,290 | $48.00 | $36.40M | 3,279,421 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-23 | 2018-05-23 | 474 | $50.50 | $23.9K | 4,037,737 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-23 | 2018-05-23 | 26 | $50.50 | $1.3K | 4,037,711 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-22 | 2018-05-23 | 5,592 | $50.86 | $284.4K | 4,038,519 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-22 | 2018-05-23 | 308 | $50.69 | $15.6K | 4,038,211 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 474 | $52.13 | $24.7K | 4,044,137 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 26 | $52.13 | $1.4K | 4,044,111 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 1,595 | $51.06 | $81.4K | 4,044,611 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | S Sale | 2018-05-21 | 2018-05-23 | 29,005 | $51.16 | $1.48M | 4,046,206 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2018-05-18 | 2018-05-21 | 61,139 | $13.16 | $804.6K | 3,466,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2018-05-17 | 2018-05-21 | 100,000 | $13.03 | $1.30M | 3,527,533 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2018-03-23 | 2018-03-23 | 5,231 | $12.02 | $62.9K | 3,627,533 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2018-03-22 | 2018-03-23 | 33,630 | $12.07 | $405.9K | 3,632,764 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2018-03-21 | 2018-03-23 | 100,000 | $12.27 | $1.23M | 3,666,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-12-07 | 2017-12-07 | 5,000 | $6.13 | $30.6K | 3,766,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-12-06 | 2017-12-07 | 15,000 | $6.09 | $91.3K | 3,771,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-12-05 | 2017-12-07 | 15,000 | $6.37 | $95.5K | 3,786,394 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | J Other | 2017-11-30 | 2017-12-04 | 99,513 | — | $0 | 4,074,216 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | J Other | 2017-11-30 | 2017-12-04 | 995 | — | $0 | 4,075,211 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-11-16 | 2017-11-16 | 5,000 | $6.99 | $35.0K | 3,801,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-11-15 | 2017-11-16 | 15,000 | $6.99 | $104.8K | 3,806,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-11-14 | 2017-11-16 | 15,000 | $7.02 | $105.3K | 3,821,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-10-05 | 2017-10-05 | 6,000 | $8.34 | $50.0K | 3,836,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-10-04 | 2017-10-05 | 14,000 | $8.59 | $120.3K | 3,842,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-10-03 | 2017-10-05 | 15,000 | $8.64 | $129.6K | 3,856,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-09-15 | 2017-09-15 | 10,000 | $7.54 | $75.4K | 3,871,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-09-14 | 2017-09-15 | 6,000 | $7.52 | $45.1K | 3,881,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-09-13 | 2017-09-15 | 8,500 | $7.49 | $63.7K | 3,887,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-08-09 | 2017-08-09 | 15,000 | $7.30 | $109.5K | 3,895,894 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-08-08 | 2017-08-09 | 5,000 | $7.98 | $39.9K | 3,910,894 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-08-07 | 2017-08-09 | 4,500 | $8.02 | $36.1K | 3,915,894 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2017-06-30 | 2017-07-05 | 2,632 | — | $0 | 2,632 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 8,618 | — | $0 | 8,618 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 6,568,527 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 1,009,693 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 2,584,959 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion deriv | 2017-05-22 | 2017-05-24 | 1,318,681 | — | $0 | 0 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 212,419 | — | $0 | 212,419 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 3,728,464 | — | $0 | 3,728,464 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | P Buy | 2017-05-22 | 2017-05-24 | 133,333 | $15.00 | $2.00M | 3,861,797 | SEC↗ |
| GTHX G1 Therapeutics, Inc. | C Conversion | 2017-05-22 | 2017-05-24 | 99,513 | — | $0 | 99,513 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-05-19 | 2017-05-19 | 15,000 | $8.31 | $124.7K | 3,920,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-05-18 | 2017-05-19 | 9,000 | $8.44 | $76.0K | 3,935,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-05-17 | 2017-05-17 | 19,000 | $8.39 | $159.4K | 3,944,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-05-16 | 2017-05-17 | 9,544 | $8.61 | $82.2K | 3,963,394 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-05-15 | 2017-05-17 | 15,941 | $8.94 | $142.5K | 3,972,938 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-04-19 | 2017-04-19 | 2,030 | $7.37 | $15.0K | 3,988,879 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-04-18 | 2017-04-19 | 44,455 | $7.48 | $332.5K | 3,990,909 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-04-17 | 2017-04-19 | 22,000 | $7.43 | $163.5K | 4,035,364 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-03-16 | 2017-03-17 | 21,485 | $6.77 | $145.5K | 4,057,364 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-03-15 | 2017-03-17 | 47,000 | $6.47 | $304.1K | 4,078,849 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-02-22 | 2017-02-22 | 2,000 | $7.49 | $15.0K | 4,125,849 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-02-21 | 2017-02-22 | 25,000 | $7.55 | $188.8K | 4,127,849 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-02-17 | 2017-02-17 | 10,000 | $7.54 | $75.4K | 4,152,849 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-02-16 | 2017-02-17 | 14,000 | $7.58 | $106.1K | 4,162,849 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-02-15 | 2017-02-17 | 17,485 | $7.64 | $133.6K | 4,176,849 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-20 | 2017-01-20 | 8,000 | $7.77 | $62.2K | 4,194,334 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-19 | 2017-01-19 | 6,478 | $8.22 | $53.2K | 1,757,719 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-19 | 2017-01-19 | 7,592 | $8.22 | $62.4K | 2,060,514 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-19 | 2017-01-20 | 15,485 | $8.23 | $127.4K | 4,202,334 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-18 | 2017-01-19 | 10,457 | $8.64 | $90.3K | 1,764,197 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-18 | 2017-01-19 | 12,258 | $8.64 | $105.9K | 2,068,106 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-18 | 2017-01-20 | 25,000 | $8.64 | $216.0K | 4,217,819 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-17 | 2017-01-19 | 8,366 | $8.92 | $74.6K | 1,774,654 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-17 | 2017-01-19 | 9,806 | $8.92 | $87.5K | 2,080,364 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2017-01-17 | 2017-01-20 | 20,000 | $8.92 | $178.4K | 4,242,819 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 1,654,531 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 1,805 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 19,900 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 21,705 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 4,071,815 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 865,881 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 675,795 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 337,897 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,035,908 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 21,705 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 432,941 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 689,388 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 1,805 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise deriv | 2016-06-07 | 2016-06-07 | 19,900 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 337,898 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 432,940 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 689,388 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion deriv | 2016-06-07 | 2016-06-07 | 2,035,907 | — | $0 | 0 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2016-06-07 | 2016-06-07 | 785,714 | $7.00 | $5.50M | 4,262,819 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2016-06-07 | 2016-06-07 | 138 | $7.00 | $966 | 3,477,105 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion | 2016-06-07 | 2016-06-07 | 3,321,785 | — | $0 | 3,433,833 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise | 2016-06-07 | 2016-06-07 | 43,410 | $0.02 | $868 | 3,477,243 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion | 2016-06-07 | 2016-06-07 | 1,598,223 | — | $0 | 1,654,248 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2016-06-07 | 2016-06-07 | 414,286 | $7.00 | $2.90M | 2,090,170 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise | 2016-06-07 | 2016-06-07 | 21,705 | $0.02 | $434 | 1,675,953 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2016-06-07 | 2016-06-07 | 69 | $7.00 | $483 | 1,675,884 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | P Buy | 2016-06-07 | 2016-06-07 | 107,142 | $7.00 | $750.0K | 1,783,020 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | S Sale | 2016-06-07 | 2016-06-07 | 69 | $7.00 | $483 | 1,675,878 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | X Exercise | 2016-06-07 | 2016-06-07 | 21,705 | $0.02 | $434 | 1,675,947 | SEC↗ |
| CLSD Clearside Biomedical, Inc. | C Conversion | 2016-06-07 | 2016-06-07 | 1,598,219 | — | $0 | 1,654,242 | SEC↗ |